Aker BioMarine AS (OSL: AKBM)

Aker BioMarine AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	9,119	4,033	3,335	4,756	10,291	-
Market Cap Growth	145.85%	20.94%	-29.89%	-53.79%	-	-
Enterprise Value	10,887	8,170	7,246	7,421	12,373	-
Last Close Price	104.00	46.00	38.05	54.30	117.50	-
PE Ratio	-	-44.18	35.11	-67.48	-196.34	-
PS Ratio	2.59	1.19	1.22	2.06	4.17	-
PB Ratio	2.65	1.09	0.89	1.46	3.23	-
P/FCF Ratio	29.31	265.14	-13.33	-7.09	-16.56	-
P/OCF Ratio	10.01	8.39	22.42	207.63	-23.58	-
EV/Sales Ratio	3.02	2.40	2.65	3.21	5.01	-
EV/EBITDA Ratio	17.83	16.15	12.04	21.88	29.09	-
EV/EBIT Ratio	507.80	138.91	45.12	-122.08	166.02	-
EV/FCF Ratio	34.99	537.11	-28.96	-11.07	-19.91	-
Debt / Equity Ratio	0.51	1.07	1.01	0.88	0.65	2.72
Debt / EBITDA Ratio	3.02	7.20	5.82	7.37	4.33	9.10
Debt / FCF Ratio	6.24	262.00	-15.01	-4.27	-3.34	-3.67
Asset Turnover	0.42	0.41	0.35	0.36	0.41	0.44
Inventory Turnover	1.54	1.17	0.97	1.38	1.68	2.18
Quick Ratio	1.49	0.83	0.83	0.92	1.05	0.64
Current Ratio	13.69	2.57	2.85	3.10	3.15	1.83
Return on Equity (ROE)	-3.11%	-2.42%	2.67%	-2.15%	-2.07%	-14.25%
Return on Assets (ROA)	0.16%	0.44%	1.29%	-0.59%	0.78%	1.04%
Return on Capital (ROIC)	0.20%	0.48%	1.40%	-0.66%	0.92%	1.21%
Earnings Yield	-0.02%	-2.26%	2.95%	-1.48%	-0.45%	-
FCF Yield	3.41%	0.38%	-7.50%	-14.10%	-6.04%	-
Buyback Yield / Dilution	-5.42%	-0.04%	-0.05%	-12.20%	-13.05%	-
Total Shareholder Return	-5.42%	-0.04%	-0.05%	-12.20%	-13.05%	-

Source: S&P Capital IQ. Standard template. Financial Sources.